Huntington National Bank »

Aclaris Therapeutics shares owned by Huntington National Bank

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Huntington National Bank from 13F filings

Historical chart of Huntington National Bank investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Huntington National Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Huntington National Bank

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.4k 458 5.29
2023-12-31 $351 334 1.05

More positions owned by Huntington National Bank

Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Alphabet Common Stock (GOOGL)
JP MORGAN CHASE & Common Stock (JPM)
Vanguard Exchange Traded (Principal) (VEA)
Ishares Exchange Traded (Principal) (IVV)
Microsoft Corp Common Stock (MSFT)
Broadcom Common Stock (AVGO)
Amazon.com Common Stock (AMZN)
Ishares Exchange Traded (Principal) (IJH)
Ishares Exchange Traded (Principal) (IJR)
ELI LILLY & Common Stock (LLY)
Advanced Micro Devices Common Stock (AMD)
State Street Exchange Traded (Principal) (SPY)
Exxon Mobil Corp Common Stock (XOM)

View all positions for Huntington National Bank

Top funds holding Aclaris Therapeutics

RA Capital Management
BML Capital Management
BlackRock
Deep Track Capital
Vivo Capital
Vanguard Capital Management
Frazier Life Sciences Management
Rock Springs Capital Management
Adage Capital Partners GP
Decheng Capital
Geode Capital Management
Morgan Stanley
Citadel Advisors
Braidwell
Balyasny Asset Management

View all funds holding Aclaris Therapeutics